232 related articles for article (PubMed ID: 20015887)
21. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases.
Jaso J; Chen L; Li S; Lin P; Chen W; Miranda RN; Konoplev S; Medeiros LJ; Yin CC
Hum Pathol; 2012 Sep; 43(9):1436-43. PubMed ID: 22406370
[TBL] [Abstract][Full Text] [Related]
22. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.
Papadaki T; Stamatopoulos K; Belessi C; Pouliou E; Parasi A; Douka V; Laoutaris N; Fassas A; Anagnostopoulos A; Anagnostou D
Am J Surg Pathol; 2007 Mar; 31(3):438-46. PubMed ID: 17325486
[TBL] [Abstract][Full Text] [Related]
23. A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma.
Cuneo A; Bardi A; Wlodarska I; Selleslag D; Roberti MG; Bigoni R; Cavazzini F; De Angeli C; Tammiso E; del Senno L; Cavazzini P; Hagemeijer A; Castoldi G
Leukemia; 2001 Aug; 15(8):1262-7. PubMed ID: 11480569
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA losses in the frequently deleted region of 7q in SMZL.
Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
[No Abstract] [Full Text] [Related]
25. Indolent lymphomas of mature B lymphocytes.
Kurtin PJ
Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.
Callet-Bauchu E; Baseggio L; Felman P; Traverse-Glehen A; Berger F; Morel D; Gazzo S; Poncet C; Thieblemont C; Coiffier B; Magaud JP; Salles G
Leukemia; 2005 Oct; 19(10):1818-23. PubMed ID: 16094418
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic problems among chronic lymphocytic leukemia and other indolent B-cell leukemias in a Japanese population.
Isobe Y; Tomomatsu J; Tsukune Y; Tsukada N; Sasaki M; Sugimoto K; Komatsu N
Intern Med; 2012; 51(15):1977-81. PubMed ID: 22864121
[TBL] [Abstract][Full Text] [Related]
29. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
30. Follicular lymphoma with prominent Dutcher body formation: a pathologic study of 3 cases in comparison with nodal or splenic lymphoplasmacytic lymphoma and marginal zone lymphoma.
Wang E; Stoecker M; Burchette J; Rehder C
Hum Pathol; 2012 Nov; 43(11):2001-11. PubMed ID: 22607703
[TBL] [Abstract][Full Text] [Related]
31. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?
Mollejo M; Algara P; Mateo MS; Sánchez-Beato M; Lloret E; Medina MT; Piris MA
Histopathology; 2002 Jan; 40(1):22-30. PubMed ID: 11903595
[TBL] [Abstract][Full Text] [Related]
32. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Dunphy CH; Perkins SL
Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
[TBL] [Abstract][Full Text] [Related]
33. An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.
Zapata M; Budnick SD; Bordoni R; Li S
Int J Clin Exp Pathol; 2010 Mar; 3(4):430-6. PubMed ID: 20490333
[TBL] [Abstract][Full Text] [Related]
34. The product of the t(11;18), an API2-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type.
Maes B; Baens M; Marynen P; De Wolf-Peeters C
Ann Oncol; 2000 May; 11(5):521-6. PubMed ID: 10907943
[TBL] [Abstract][Full Text] [Related]
35. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
Ondrejka SL; Lai R; Smith SD; Hsi ED
Haematologica; 2011 Aug; 96(8):1121-7. PubMed ID: 21508124
[TBL] [Abstract][Full Text] [Related]
36. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
37. CD5 negative diffuse mantle cell lymphoma with splenomegaly and bone marrow involvement.
Bell ND; King JA; Kusyk C; Nelson BP; Sendelbach KM
South Med J; 1998 Jun; 91(6):584-7. PubMed ID: 9634125
[TBL] [Abstract][Full Text] [Related]
38. De novo CD5+ diffuse large B-cell lymphomas. A heterogeneous group containing an unusual form of splenic lymphoma.
Kroft SH; Howard MS; Picker LJ; Ansari MQ; Aquino DB; McKenna RW
Am J Clin Pathol; 2000 Oct; 114(4):523-33. PubMed ID: 11026098
[TBL] [Abstract][Full Text] [Related]
39. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.
Piris MA; Mollejo M; Campo E; Menárguez J; Flores T; Isaacson PG
Histopathology; 1998 Sep; 33(3):230-9. PubMed ID: 9777389
[TBL] [Abstract][Full Text] [Related]
40. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity.
Thieblemont C; Felman P; Callet-Bauchu E; Traverse-Glehen A; Salles G; Berger F; Coiffier B
Lancet Oncol; 2003 Feb; 4(2):95-103. PubMed ID: 12573351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
